Article info
Research ethics
Patients' views of consent in clinical trials for acute myocardial infarction: impact of trial design
- Correspondence to Dr Neal W Dickert, Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1462 Clifton Road, #508, Atlanta, GA 30322, USA; njr{at}emory.edu
Citation
Patients' views of consent in clinical trials for acute myocardial infarction: impact of trial design
Publication history
- Received August 5, 2016
- Revised November 21, 2016
- Accepted December 7, 2016
- First published December 30, 2016.
Online issue publication
July 26, 2017
Article Versions
- Previous version (30 December 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Involving patients in enrolment decisions for acute myocardial infarction trials
- Patients’ perceptions of informed consent in acute myocardial infarction research: a questionnaire based survey of the consent process in the DANAMI-2 trial
- Observational study of parental opinion of deferred consent for neonatal research
- The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial
- Can informed consent to research be adapted to risk?
- Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry
- Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction
- Deferred consent for the enrolment of neonates in delivery room studies: strengthening the approach
- Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty
- Comparison of epidemiology, treatments and outcomes of ST segment elevation myocardial infarction between young and elderly patients